Log in

Eyepoint Pharmaceuticals SEC Filings & 10K Form (NASDAQ:EYPT)

$1.45
-0.50 (-25.64 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$1.39
Now: $1.45
$1.49
50-Day Range
$1.44
MA: $1.75
$2.05
52-Week Range
$1.19
Now: $1.45
$2.79
Volume7.50 million shs
Average Volume428,588 shs
Market Capitalization$156.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

SEC Filings

Eyepoint Pharmaceuticals (NASDAQ:EYPT) SEC Filings

DateFilerForm TypeView
02/20/2020
3:28 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
02/04/2020
5:02 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
12:11 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2020
10:58 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K/A
11/27/2019
4:22 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
10:41 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
8:54 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
7:42 AM
Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
7:41 AM
Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
3:37 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
5:04 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2019
5:03 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
5:13 PM
Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:46 AM
Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:05 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K/A
08/22/2019
4:25 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:38 PM
Eyepoint Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2019
2:37 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
6:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:02 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
3:39 PM
DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
3:37 PM
DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/11/2019
3:02 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
4:04 PM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:04 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
4:03 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:53 PM
Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:52 PM
Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:52 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:51 PM
Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:51 PM
Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:51 PM
Eyepoint Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:50 PM
ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:50 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:49 PM
Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:48 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:31 PM
Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:29 PM
Eyepoint Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:29 PM
Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
3:28 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:42 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:41 PM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:40 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:38 PM
Eyepoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:34 PM
Eyepoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2019
8:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
6:01 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
4:30 PM
Eyepoint Pharmaceuticals (Filer)
Form DEFA14A
04/29/2019
4:29 PM
Eyepoint Pharmaceuticals (Filer)
Form DEF 14A
04/26/2019
7:49 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
7:16 AM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
7:25 AM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
7:24 AM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:01 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
7:23 AM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
7:21 AM
Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
7:20 AM
Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
4:29 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
03/27/2019
3:27 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
03/21/2019
4:24 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:22 PM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
4:30 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-KT
03/14/2019
6:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
3:00 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
1:36 PM
EW Healthcare Partners, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13D/A
02/13/2019
1:31 PM
Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/29/2019
3:08 PM
Eyepoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:02 PM
Eyepoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2019
3:02 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
3:59 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
01/18/2019
3:50 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2019
7:29 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:06 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2018
3:06 PM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
11:15 PM
Eyepoint Pharmaceuticals (Filer)
Form EFFECT
11/28/2018
4:18 PM
Eyepoint Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/16/2018
3:00 PM
Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
3:23 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
6:20 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
11:15 PM
Eyepoint Pharmaceuticals (Filer)
Form EFFECT
10/31/2018
4:29 PM
Eyepoint Pharmaceuticals (Filer)
Form S-3/A
10/29/2018
3:36 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-K/A
10/29/2018
3:03 PM
Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
3:00 PM
Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2018
3:00 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2018
3:00 PM
Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2018
3:00 PM
Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
4:13 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2018
3:05 PM
ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:02 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
4:31 PM
Eyepoint Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/18/2018
3:15 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/12/2018
4:27 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2018
6:06 PM
Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
8:02 AM
Eyepoint Pharmaceuticals (Filer)
Form S-3/A
08/03/2018
3:06 PM
Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2018
3:05 PM
Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/03/2018
3:01 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2018
4:27 PM
Eyepoint Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Stock Symbol

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel